Transforming the Genomic Diagnosis and Management of Severe Neurocognitive Disorders. [CRE APP1117394 - Funded by NHMRC; Awarded $2,499,329]
- Schofield, Deborah (Primary Chief Investigator)
- Roscioli, Tony (Chief Investigator)
- Gecz, Jozef (Chief Investigator)
- Field, Michael (Chief Investigator)
- Buckley, Michael (Chief Investigator)
- North, Kathryn N. (Chief Investigator)
- Dinger, Marcel (Chief Investigator)
- Christodoulou, John (Chief Investigator)
- Amor, David J. (Chief Investigator)
- Baynam, Gareth (Chief Investigator)
- Boddy, Alan V. (Associate Investigator)
- Colley, Alison (Associate Investigator)
- Schenck, Annette (Associate Investigator)
- Barnett, Christopher (Associate Investigator)
- Goodnow, Christopher (Associate Investigator)
- Mowat, David (Associate Investigator)
- McGaughran, Julie (Primary Chief Investigator)
- Caulfield, Mark J. (Associate Investigator)
- Dudding, Tracy (Associate Investigator)
- Groza, Tudor (Associate Investigator)
- The University of Adelaide
- Hunter Genetics
- Prince of Wales Hospital
- Murdoch Children's Research Institute
- King Edward Memorial Hospital for Women
- Radboud University
- Royal Brisbane Hospital
- GOLD service and Hunter Genetics
- The University of New South Wales
- The Garvan Institute of Medical Research
- University of Sydney
- The University of Queensland
- Sydney Children's Hospital Network
- Queen Mary University of London
Project: Other